ID Biomedical Overview
- Year Founded
-
1991
- Status
-
Acquired/Merged
- Employees
-
113
- Latest Deal Type
-
M&A
- Financing Rounds
-
4
- Investments
-
3
ID Biomedical General Information
Description
Operator of an integrated biotechnology company intended to help clients in the development of innovative vaccine products. The company specializes in the research, development, manufacturing, sales, and marketing of vaccines for influenza, streptococcus in children, and other vaccines for respiratory viruses and bioterror agents.
Contact Information
Website
www.idbiomedical.comCorporate Office
- 1630 Waterfront Center
- 200 Burrard Street
- Vancouver, British Columbia V6C 3L6
- Canada
Corporate Office
- 1630 Waterfront Center
- 200 Burrard Street
- Vancouver, British Columbia V6C 3L6
- Canada
ID Biomedical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
ID Biomedical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
ID Biomedical Patents
ID Biomedical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-1536831-A2 | Pharmaceutical liposomal compositions containing n. meningitidis derived polypeptides or polynucleotides | Inactive | 30-Aug-2002 | ||
| EP-1456231-A2 | Streptococcus antigens | Inactive | 20-Dec-2001 | ||
| EP-1444349-B1 | Polypeptides of moraxella (branhamella) catarrhalis | Inactive | 16-Nov-2001 | ||
| EP-1444349-A2 | Process for the preparation of ramipril | Active | 16-Nov-2001 | ||
| EP-1458752-A2 | Polypeptides of pseudomonas aeruginosa | Inactive | 13-Nov-2001 | C07K14/21 |
ID Biomedical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
ID Biomedical Acquisitions (3)
ID Biomedical’s most recent deal was a Merger/Acquisition with Shire Pharmaceuticals (vaccine business) for . The deal was made on 09-Sep-2004.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Shire Pharmaceuticals (vaccine business) | 09-Sep-2004 | Merger/Acquisition | Pharmaceuticals | ||
| Intellivax | 16-May-2001 | Merger/Acquisition | Biotechnology | ||
| Meiogenics | 18-Dec-1992 | Merger/Acquisition | Biotechnology |
ID Biomedical FAQs
-
When was ID Biomedical founded?
ID Biomedical was founded in 1991.
-
Where is ID Biomedical headquartered?
ID Biomedical is headquartered in Vancouver, Canada.
-
What is the size of ID Biomedical?
ID Biomedical has 113 total employees.
-
What industry is ID Biomedical in?
ID Biomedical’s primary industry is Drug Discovery.
-
Is ID Biomedical a private or public company?
ID Biomedical is a Private company.
-
What is the current valuation of ID Biomedical?
The current valuation of ID Biomedical is .
-
What is ID Biomedical’s current revenue?
The current revenue for ID Biomedical is .
-
How much funding has ID Biomedical raised over time?
ID Biomedical has raised $13.8M.
-
When was ID Biomedical acquired?
ID Biomedical was acquired on 08-Dec-2005.
-
Who acquired ID Biomedical?
ID Biomedical was acquired by GSK.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
